P53 ALTERATIONS SHOW SIGNIFICANT CORRELATION WITH GENE AMPLIFICATION AND S-PHASE INDEX IN BREAST-CANCER

被引：0
|
作者：
CERVANTES, M
ZHOU, HY
SAHIN, A
DHINGRA, K
VALERO, V
ORDONEZ, N
ELNAGGAR, A
HESS, K
GLASSMAN, A
SEN, S
机构：
[1] UNIV TEXAS, MD ANDERSON CANC CTR, DIV LAB MED, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANC CTR, DIV PATHOL, HOUSTON, TX 77030 USA
[3] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT BREAST & GYNECOL MED ONCOL, HOUSTON, TX 77030 USA
[4] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT BIOMATH, HOUSTON, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF ONCOLOGY | 1995年 / 6卷 / 05期
关键词：
P53; ONCOGENES; FLOW CYTOMETRY; BREAST CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correlation of p53 gene/protein alterations with incidence of oncogene amplification, a potential marker of prognosis, was evaluated in 26 fresh breast cancer samples. p53 gene was analyzed by SSCP and DNA sequencing while p53 protein status was investigated by immunohistochemistry (IH). Amplification of c-erbB2/neu, c-myc, N-ras, int-2, hst, PRAD-1 and EGFR genes was studied by slot blot and in situ hybridizations. p53 alterations were found in 31% cases by SSCP and 42% by IH; gene amplification was detected in 27% cases. p53 gene alterations correlated significantly with gene amplification (p=0.006) and also with higher S-phase index (p=0.026), aneuploidy (p=0.026) and negative progesterone receptor status (p=0.043).
引用
收藏
页码：955 / 962
页数：8
相关论文
共 50 条
  • [31] P53 PROTEIN OVEREXPRESSION AND CHEMOSENSITIVITY IN BREAST-CANCER
    MAKRIS, A
    POWLES, TJ
    DOWSETT, M
    ALLRED, C
    LANCET, 1995, 345 (8958): : 1181 - 1182
  • [32] P53 MUTATIONS OCCUR IN AGGRESSIVE BREAST-CANCER
    MAZARS, R
    SPINARDI, L
    BENCHEIKH, M
    SIMONYLAFONTAINE, J
    JEANTEUR, P
    THEILLET, C
    CANCER RESEARCH, 1992, 52 (14) : 3918 - 3923
  • [33] PROGNOSTIC VALUE OF THE S-PHASE FRACTION OF BREAST-CANCER
    REMVIKOS, Y
    BRITISH JOURNAL OF CANCER, 1993, 68 (02) : 433 - 434
  • [34] Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy
    Chevillard, S
    Lebeau, J
    Pouillart, P
    de Toma, C
    Beldjord, C
    Asselain, B
    Klijanienko, J
    Fourquet, A
    Magdelenat, H
    Vielh, P
    CLINICAL CANCER RESEARCH, 1997, 3 (12) : 2471 - 2478
  • [35] Circulating p53 antibodies as early markers of oral cancer: Correlation with p53 alterations
    Ralhan, R
    Nath, N
    Agarwal, S
    Mathur, M
    Wasylyk, B
    Shukla, NK
    CLINICAL CANCER RESEARCH, 1998, 4 (09) : 2147 - 2152
  • [36] THE S-PHASE FRACTION IN BENIGN MASTOPATHY AND BREAST-CANCER
    KUNZ, J
    WINZER, KJ
    ZENTRALBLATT FUR CHIRURGIE, 1991, 116 (07): : 483 - 486
  • [37] Mdm2 gene amplification in gastric cancer correlation with expression of mdm2 protein and p53 alterations
    Günther, T
    Schneider-Stock, R
    Häckel, C
    Kasper, HU
    Pross, M
    Hackelsberger, A
    Lippert, H
    Roessner, A
    MODERN PATHOLOGY, 2000, 13 (06) : 621 - 626
  • [38] Barrett's metaplasia and p53 gene alterations
    Campomenosi, P
    Bogliolo, M
    Urbini, S
    Abbondandolo, A
    Fronza, G
    RECENT ADVANCES IN DISEASES OF THE ESOPHAGUS: SELECTED PAPERS IN 6TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR DISEASES OF THE ESOPHAGUS, 1996, : 825 - 829
  • [39] FREQUENT P53 GENE-MUTATIONS AND NOVEL ALLELES IN FAMILIAL BREAST-CANCER
    GLEBOV, OK
    MCKENZIE, KE
    WHITE, CA
    SUKUMAR, S
    CANCER RESEARCH, 1994, 54 (14) : 3703 - 3709
  • [40] Antibody to p53. A new method for investigating alterations in the p53 gene. Use in breast cancer
    Soussi, T
    Peyrat, JP
    Lubin, R
    Bonneterre, J
    PATHOLOGIE BIOLOGIE, 1996, 44 (04): : 232 - 234
12345